STOCK TITAN

Peraso, Inc. 10-Q Filings

PRSO NASDAQ

Every 10-Q that Peraso, Inc. (PRSO) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 10-Q covers the quarterly report filed between annual reports, so if you follow PRSO and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full PRSO filings page.

Rhea-AI Summary

Peraso Inc., a fabless mmWave semiconductor company, reported sharp revenue declines and continued losses for the three and six months ended June 30, 2026. Total net revenue was $1.3 million for the quarter and $2.3 million year-to-date, down significantly from 2025 as memory IC and mmWave IC shipments fell and demand from fixed wireless access customers softened.

The company posted a quarterly net loss of $2.2 million and a six‑month net loss of $4.7 million, with an accumulated deficit of $186.6 million. Cash and cash equivalents were $3.3 million and working capital $4.0 million, while operating activities used $3.9 million of cash in the first half. Management concluded there is substantial doubt about the ability to continue as a going concern for at least 12 months.

To support liquidity, Peraso raised $4.7 million in net proceeds through at‑the‑market stock sales in the first half and established a $25.0 million committed equity facility with Roth Principal Investments, subject to share caps and other conditions. The company also has approximately $2.4 million of non‑cancelable inventory purchase obligations outstanding.

Rhea-AI Summary

Peraso Inc. reported very weak first-quarter 2026 results while continuing to face serious liquidity pressures. Net revenue fell to $963,000 from $3.9 million a year earlier, mainly due to a sharp drop in memory IC and mmWave product sales, partly offset by higher engineering services.

The company posted a net loss of $2.5 million, compared with a $471,000 loss in the prior-year quarter, and used $2.3 million of cash in operating activities. Cash and cash equivalents were $2.7 million and working capital was $4.0 million as of March 31, 2026.

Management and the auditor both state there is substantial doubt about Peraso’s ability to continue as a going concern, as recurring losses and negative cash flows are expected to persist without additional capital. The company is relying heavily on its at-the-market equity program, which raised about $2.3 million in Q1 and a further $2.1 million after quarter-end. Peraso is also running a strategic review and remains in discussions with Mobix Labs regarding a potential stock-based transaction, with no assurance any deal will occur.

Rhea-AI Summary

Peraso Inc. reported Q3 results with total net revenue of $3.234 million, down 20% year over year, as the business shifts from legacy memory ICs to mmWave products. Product revenue was $3.062 million, led by mmWave ICs of $2.276 million, while memory ICs contributed $0.072 million following the product line’s end‑of‑life. Gross profit was $1.817 million.

Net loss for the quarter was $1.210 million (basic and diluted loss per share of $0.17), compared with a $2.712 million net loss a year ago. Cash and cash equivalents were $1.865 million at quarter end, and operating cash outflow was $4.555 million for the first nine months. The company raised liquidity through an ATM program (net $2.270 million year‑to‑date) and warrant inducement offerings (net $0.933 million earlier and approximately $0.9 million in September). Management states substantial doubt about the company’s ability to continue as a going concern absent additional capital. Peraso is conducting a strategic review and, on October 30, 2025, entered a mutual confidentiality agreement with Mobix Labs regarding its unsolicited proposals. Peraso also regained compliance with Nasdaq’s $1.00 minimum bid price on September 19, 2025.

Rhea-AI Summary

Peraso Inc. reported total net revenue of $2.22 million for the quarter and $6.09 million for the six months ended June 30, 2025, with product sales shifting away from discontinued memory ICs toward mmWave ICs and antenna modules. The company recorded a net loss of $1.83 million for the quarter and $2.30 million for the six months, and had cash and cash equivalents of $1.76 million and an accumulated deficit of approximately $179.4 million as of June 30, 2025.

The company completed final end-of-life shipments for its memory ICs in March 2025, reported improved six-month gross profit driven by mmWave product sales, reduced R&D and SG&A costs, and raised proceeds from at-the-market sales. The board has launched a strategic review after receiving an unsolicited, non-binding proposal from Mobix Labs and is pursuing additional financings. Management and the auditor have expressed substantial doubt about the company’s ability to continue as a going concern without additional capital.